Health Care/Hospital
Benchling Reveals the Next Chapter of R&D at Benchtalk 2025
Benchling AI debuts alongside major new capabilities for antibody discovery, automated data analysis, and development BOSTON, Oct. 14, 2025 /PRNewswire/ -- Benchling today unveiled major new capabilities at Benchtalk, its annual customer conference. These new releases are designed to help biotec...
2025-10-14 21:14
1340
Pictor's Proteomics Platform Offers Promising Advancement for Detecting Mycoplasma bovis in Cattle
New research highlights the Pictor PictVet™ Mycoplasma bovis IgG Multiplex ELISA's enhanced analytical performance through multiplexing and its potential to enhance global disease management. CARLSBAD, Calif., Oct. 14, 2025 /PRNewswire/ -- Mycoplasma bovis is a devastating pathogen that threate...
2025-10-14 21:00
923
India's No:1 Ranked Institute IIT Madras partners with Hyundai Motor India to launch 'Hyundai Hope for Cancer' to revolutionize Paediatric Cancer Care
CHENNAI, India, Oct. 14, 2025 /PRNewswire/ -- Indian Institute of Technology Madras (IIT Madras),India's No:1 Ranked Educational Institution, is partnering with Hyundai Motor India Foundation (HMIF), the CSR arm of Hyundai Motor India Limited (HMIL), to launch 'Hyundai Hope for Cancer' - a pionee...
2025-10-14 20:30
1038
Asia University Partners with NucleicAI to Build a Sovereign AI Life Science Data Platform
TAICHUNG, Oct. 14, 2025 /PRNewswire/ -- Asia University
2025-10-14 20:00
997
Infosys Chosen by NHSBSA to Deliver a New Workforce Management Solution for the NHS in England and Wales
Next-Generation solution supports the NHS 10-year Health Plan and the mission
to create a workforce that is fit for the future
LONDON and BENGALURU, India, Oct. 14, 2025 /PRNewswire/ -- Infosys
2025-10-14 18:02
1029
Ascletis Completes Denifanstat (ASC40) Pre-NDA Consultation with China National Medical Products Administration
- Denifanstat (ASC40) met all primary, key secondary and secondary efficacy endpoints (ITT analysis) and significantly improved moderate-to-severe acne vulgaris compared with placebo in a Phase III randomized, double-blind, placebo-controlled, multicenter clinical trial. HONG KONG, Oct. 14, 2025...
2025-10-14 18:00
1314
Kyoto University Engineering Ph.D. Team Realizes Achievement Transformation in Chengdu; LivingPhoenix's Biomimetic Collagen Rated "International Leading-Edge"
—— Globally Pioneering POGMENT Triple-Helix Biomimetic Collagen Debuts at Chinese Biomaterials Congress 2025 CHENGDU, China, Oct. 14, 2025 /PRNewswire/ -- The 2025 Chinese Biomaterials Congress was recently held in Shaoxing,Zhejiang, gathering leading experts including academicians from the Chin...
2025-10-14 17:22
1447
Telix Reports US$206M Revenue, FY 2025 Guidance Upgraded
MELBOURNE, Australia and INDIANAPOLIS, Oct. 14, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today provides an update on its commercial and operational performance for the quarter ended30 September 2025 (Q3 2025). All figures are in USD unless stated otherwi...
2025-10-14 14:59
1434
Great Novel Therapeutics Biotech & Medicals Corporation (GNTbm) Presented Preclinical Data on GNTbm-TKI, a Novel Multi-tyrosine Kinase Inhibitor with Potent Immune Activation, at the 2025 ESMO Annual Meeting
TAIPEI, Oct. 14, 2025 /PRNewswire/ -- GNTbm (stock code: 7427, Taiwan) announced the preclinical data on GNTbm-TKI, a novel multi-receptor tyrosine kinase inhibitor for cancer immunotherapy. GNTbm-TKI will be presented as posters at the 2025European Society for Medical Oncology (ESMO) Annual Meet...
2025-10-14 14:26
940
2025 ACR Abstract Released! Exciting Data from Telitacicept's Phase III Clinical Study in Sjögren's Syndrome in China
* In the results of China Phase III clinical trial announced at the 2025 ACR, Telitacicept demonstrated statistically significant and clinically meaningful improvements in ESSDAI [EULAR (European League Against Rheumatism) Sjögren's Syndrome Disease Activity Index] compared to placebo. * Teli...
2025-10-14 13:44
501
HKEX to Introduce Hang Seng Biotech Index Futures
* Hang Seng Biotech Index Futures to launch on 28 November 2025 * New futures contracts offer risk management tools for one of the fastest growing sectors inHong Kong capital markets * SFC Transaction Levy Exemption will be applied for the first six months from launch HONG KONG, Oct. 14, 202...
2025-10-14 12:43
1730
Everest Medicines Announces First Patient Enrolled in a Global Multi-Center Phase I Clinical Trial of Tumor-Associated Antigen Cancer Vaccine EVM14
SHANGHAI, Oct. 14, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that the first patient has been enro...
2025-10-14 12:13
1210
PRC-Saltillo Expands Global Reach with Launch of Singapore Subsidiary
SINGAPORE, Oct. 14, 2025 /PRNewswire/ -- PRC-Saltillo, a leading provider of AAC (Augmentative and Alternative Communication) devices and support services, is proud to announce the official launch of its wholly owned subsidiary, PRC Saltillo Singapore Pte. Ltd. As PRC-Saltillo enters its 60th ye...
2025-10-14 08:00
992
NABR Comment on IUCN Determination
WASHINGTON, Oct. 14, 2025 /PRNewswire/ -- The International Union for
Conservation of Nature (IUCN) issued a decision onOctober 9, 2025, to retain
the "Endangered" status determination for long-tailed macaque ("LTM") monkeys (
Macaca fascicularis).
2025-10-14 06:55
1186
Compass, the revolutionary application that aims to reduce the risk of developing Type 2 diabetes
SYDNEY, Oct. 14, 2025 /PRNewswire/ -- Approximately 1 million Australian adults
have Type 2 diabetes and it is estimated over 2 million people are pre-diabetic
or are at high risk of developing the disease.*Miroma Project Factory (MPF)
2025-10-14 05:07
1456
Waters Launches Charge Detection Mass Spectrometry Technology to Accelerate the Development of Next-Generation Biotherapeutics
Headlines: * Xevo™ CDMS facilitates direct, accurate mass detection for the largest, most heterogeneous biomolecules.1 * Enables accurate analysis of protein complexes, nucleic acids, and gene delivery vehicles, including distinguishing between empty, partial, full, and overfull viral vector...
2025-10-13 20:36
1333
Chiron Medical Launches "Early Check, Early Hope" Campaign, Embracing Pink for Breast Cancer Awareness
HONG KONG, Oct. 13, 2025 /PRNewswire/ -- According to government statistics[1], breast cancer ranks as the third leading cause of cancer deaths among women in Hong Kong, with an average of one in every 14 women likely to be diagnosed with the disease in their lifetime. The medical community widely...
2025-10-13 19:46
1047
LTS expands its CDMO capabilities with the acquisition of Renaissance Lakewood
ANDERNACH, Germany, Oct. 13, 2025 /PRNewswire/ -- LTS LOHMANN Therapie-Systeme AG ("LTS"), a leading pharmaceutical technology company today announces the acquisition of Renaissance Lakewood, LLC ("Renaissance"), a US-based contract development and manufacturing organization (CDMO) specializing i...
2025-10-13 18:00
1178
AnnJi Showcases Clinical Breakthrough of AJ201 at WMS 2025
TAIPEI, Oct. 13, 2025 /PRNewswire/ -- AnnJi Pharmaceutical Co., Ltd. (AnnJi, TWSE: 7754) announced that the Phase 2a clinical result of AJ201 for spinal and bulbar muscular atrophy (SBMA, also known as Kennedy's disease) was selected as one of the seven Late-Breaking Abstracts at the World Muscle...
2025-10-13 16:03
1160
The 138th Canton Fair is Set to Open in Guangzhou on October 15
GUANGZHOU, China, Oct. 13, 2025 /PRNewswire/ -- The 138th China Import and Export Fair (Canton Fair) is set to open inGuangzhou from October 15 to November 4, divided into three phases. The fair will maintain its 24-hour online presence to offer global buyers continuous access to Chinese supplier...
2025-10-13 14:42
2218
Week's Top Stories
Most Reposted
Amorepacific Showcases Innovative Technologies at CES 2026
[Picked up by 291 media titles]
2026-01-05 12:14
Radisson Hotel Group Revives Bangkok Icon with Opening of Radisson Hotel Chateau de Bangkok
[Picked up by 283 media titles]
2026-01-06 10:45
Panduit Announces Key Executive Appointments to Support Strategic Growth and Innovation
[Picked up by 282 media titles]
2026-01-07 10:00
iQIYI LAND Yangzhou to Open on February 8, Marking New Chapter in China's Immersive Entertainment Scene
[Picked up by 280 media titles]
2026-01-01 10:00
Space Summit 2026 to Convene Global Leaders in Singapore to Address the Growing Space Economy
[Picked up by 272 media titles]
2026-01-07 15:27Most Read
China Daily Launches "China Bound" -- An English-Language Smart-Tourism Service Platform for International Travelers
2026-01-01 17:04
8931
iQIYI LAND Yangzhou to Open on February 8, Marking New Chapter in China's Immersive Entertainment Scene
2026-01-01 10:00
8139
Domestic GPU Leader Biren Technology Listed on Hong Kong Stock Exchange
2026-01-02 17:41
7546
